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Porcine circovirus associated diseases (PCVAD) caused by PCV2 are re-
sponsible for severe economic losses in the swine industry. The mechanism of 
PCV2 replication has not been fully elucidated yet. PCV2 may be successfully 
rescued by means of either an infectious DNA clone containing the full length of 
the viral genomic DNA, or from PCV2-infected clinical tissues in PK15 cell cul-
ture. However, viruses harvested by both methods have low titres. In this study, 
PCV2 was prepared with a higher titre from PK15 cells infected by recombinant 
baculoviruses containing 1PCV2 (one stem-loop structure) or 1.1PCV2 (two 
stem-loop structure) genomic DNA copy. In addition, infectious DNA clones con-
taining two stem-loop structures in either plasmid or baculovirus backbones are 
capable of generating a higher virus titre than the DNA clones with only one copy 
of stem-loop structure.  
Key words: PCV2, infectious clone, stem loop structure, baculovirus, viral 
vector  
Porcine circovirus type 2 (PCV2) is an important viral pathogen of swine 
(Madec et al., 2008), the causative agent of porcine circovirus associated dis-
eases (PCVAD), which have caused severe economic losses in the global swine 
industry (Opriessnig et al., 2007). PCV2 is a non-enveloped single-stranded 
DNA virus belonging to the genus Circovirus in the family Circoviridae 
(Cheung, 2003b). Its ambisense circular genomic DNA (1767–1768 bases) en-
codes viral proteins both by the anti-sense strand for capsid protein (Cap) and by 
the sense strand for replication-related enzymes (Rep and Rep’) (Cheung, 2012). 
This virus replicates its genome via a rolling-circle replication mechanism in a 
manner similar to the Geminiviridae family (Cheung, 2006).  
Baculovirus derived from the Autographa californica nuclear polyhedro-
sis virus (AcMNPV) (Vail et al., 1971) has been developed as a baculovirus ex-
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pression vector system (BEVS) and widely employed for large-scale production 
(in insect cells) of numerous proteins originating from either prokaryotic or eu-
karyotic sources (van Oers et al., 2015). Modified baculovirus (called Bacman) 
can express exogenous genes in mammalian cells when controlled by promoters 
active in those cells (Roy et al., 2013; Sung et al., 2014). The BEVS has also 
been used for the preparation of other viral stocks (Kotin, 2011). Adeno-
associated virus (AAV) vectors produced by recombinant baculovirus and gene 
therapy treatment based on this vector have been registered (Haddley, 2013). 
In the present study, we describe the development of a baculovirus-driven 
gene delivery system in the PK15 cell line for the generation of PCV2. High ti-
tres of this virus were successfully rescued from PK15 cell culture through a re-
combinant baculovirus system. Rescued virus was passaged serially in PK15 
cells with a titre of 106.5 TCID50/ml. This system for the preparation of PCV2 
from cell culture is expected to provide a useful and robust tool for PCV2 re-
search. 
 
Materials and methods 
Construction of 1.1 copy of PCV2 genome by overlapping polymerase chain  
reaction (PCR) 
One copy of PCV2 genomic DNA was amplified from a PCV2 strain 
(GenBank accession number: KJ437192) using PCR with primers 1 and 2 (Table 1). 
Both SL-Rep (containing one stem-loop and rep gene sequence) and Cap-SL 
(containing cap gene sequence and one stem-loop) fragments were amplified us-
ing PCR with primers 3 and 6, respectively (Table 1). These fragments were sub-
sequently assembled into a 1.1 copy genomic DNA fragment (named 1.1PCV2) 
construct by overlapping PCR using Pfu DNA Polymerase (Transgen, China). 
The resultant plasmids (pSP72-1.1PCV2 and pSP72-PCV2, pFastBacI-1.1PCV2 
and pFastBacI-PCV2) were constructed by inserting either a 1.1 or 1 copy of 
PCV2 genomic DNA fragment into double-digested pSP72 or pFastBacI vector 
(KpnI and HindIII), respectively. Ligation products were transformed into DH5α 
competent cells and inserts confirmed by DNA sequencing. 
Generation of recombinant baculoviruses and monoclonal antibody 
Sf9 cells were cultured in Sf-900 II SFM insect media (Thermo Fisher 
Scientific, USA) at 27 °C and the Bac-to-Bac® Baculovirus Expression System 
was used to prepare recombinant baculovirus according to the manufacturer’s in-
structions (Thermo Fisher Scientific, USA). PCV2 VLPs were prepared from E. 
coli in our laboratory (Zhang et al., 2016), and monoclonal antibody was pro-
duced as described previously (Walker et al., 2000). 
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Table 1 
Primers for plasmid construction and gene detection 
Product Primer Sequence Product length 
PCV2  
genome 
 
1 
 
5’-CGGGGTACCACTGAGTCTTTTTTATCACTTCG-3’(991-1012) 
 
1768 bp 
 2 5’-CCCAAGCTTAAGACTCAGTAATTTATTTCATATGG(1000-975)  
SL-Rep 3 5’-CGGGGTACCTCCTTGGATACGTCATAGCTGAAAACG-3’  
KpnI (736-762) 
 
1077bp 
 4 5’-CCATTACGAAGTGATAAAAAAGACTCAGTAATTTATTTC 
ATATGG-3’ (1784-1759) 
 
Cap- SL 5 5’-GAAATAAATTACTGAGTCTTTTTTATCACTTCGTAATGG-3’ 
(7-35) 
 
862bp 
 6 5’-CCCAAGCTTTCTTCTTGCTGGGCATGTTGCTGC-3’ Hind III 
(850-827) 
 
Rep 7 Forward:5’-ATGACGTATCCAAGGAGGCG-3’ 945bp 
 8 Reverse: 5’-TTAGGGTTTAAGTGGG-3’  
Cap 9 Forward: 5’-ATGCCCAGCAAGAAGAATGG-3’ 702bp 
 10 Reverse: 5’-TCAGTAATTTATTTC-3’  
Note: italics indicate restriction enzyme site, GGTACC means KpnI, AAGCTT means HindIII 
 
Generation of PCV2 
PK15 cells free of PCV1 contamination were maintained in Dulbecco’s 
modified Eagle’s medium (DMEM, Invitrogen, USA) and supplemented with 
10% (v/v) heat-inactivated fetal bovine serum (FBS, Invitrogen, USA), 100 μg/ml 
of streptomycin, and 100 IU/ml of penicillin (Invitrogen, USA). For chemical 
transfection, PK15 cells were seeded (5×105 cells/well) in 6-well plates in DMEM 
cultural medium and grown to approximately 60–80% confluence, and then the 
cells were washed with DMEM twice. Finally, cells were transfected with 
pSP72-1.1PCV2 or pSP72-PCV2 using Lipofectamine 2000 (Invitrogen, USA) 
respectively, according to the manufacturer’s protocol, or infected with recombi-
nant baculovirus (Bac-PCV2 or Bac-1.1PCV2) diluted in PBS at a multiplicity of 
infection (MOI) of 100 for 1 h (Lucifora et al., 2008). After transfection or infec-
tion, cells were washed with PBS twice, supplemented with 2 ml of fresh me-
dium and cultured at 37 °C with 5% CO2 for up to 3 days. Mock-infected cells 
and wild-type baculovirus infected cells were used as controls. Reverse transcrip-
tion polymerase chain reaction (RT-PCR), Western blot (WB) and immunofluo-
rescence assay (IFA) were used to detect the genome expression of PCV2 carried 
by baculovirus. At selected time points, supernatants were collected and frozen at 
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–80 °C or transfected cells were digested with trypsin and passaged into a new 
six-well plate for serial passage as described previously (Tischer et al., 1987). 
Detection of PCV2 cap and rep gene using RT-PCR 
Total RNA was extracted from PK-15 cells harvested 72 h post-transfection 
or infection using Trizol (Invitrogen, USA), followed by RNase-free DNase I 
(TaKaRa, Japan) treatment. Synthesis of cDNA s was done with RevertAidTM 
First Strand cDNA Synthesis Kit (MBI Fermentas, USA) with oligo (dT) 18 
primer according to the manufacturer’s protocol. Then PCR was performed in a 
50-μl reaction mixture with the Pfu polymerase (Transgen, France) using primers 
7–10 (Table 1). The PCR products were separated on 1% agarose gel, purified by 
QIAquick Gel Extraction kits (Qiagen, USA) according to the manufacturer’s 
protocol, cloned into the pMD-18T vector by the TA cloning strategy, and se-
quenced. 
Detection of PCV2 Cap protein using Western blot 
PK-15 cells harvested 72 h post-transfection or post-infection were 
trypsinised and resuspended in 2 × SDS-PAGE sample buffer in the presence of 
10% beta-mercaptoethanol. Proteins were separated with 12% SDS-PAGE and 
transferred onto PolyScreen PVDF membrane in a transfer chamber (Bio-Rad, 
Hercules, USA) according to the manufacturer’s instructions. The membrane was 
then blocked with PBS containing 5% bovine serum album (BSA) for 1 h, 
washed three times with PBST and inoculated with an appropriate dilution of 
monoclonal antibody (made in our laboratory) specific to Cap for 1 h at room 
temperature. The membrane was washed three times with PBST, and then incu-
bated with HRP-conjugated anti-mouse IgG secondary antibody (Invitrogen, 
USA) for 1 h at room temperature. Finally, the membrane was soaked in a chro-
mogen/substrate solution (TMB signal solution, Invitrogen, USA) for colour de-
velopment. Images were captured on a chemiluminescent imaging system (Bio-
Rad, USA). PCV2- (GenBank accession number: KJ437192) infected cells and 
wild-type baculovirus infected cells were used as controls. 
Immunofluorescence assay (IFA) and infectivity analysis of rescued virus 
Transfection efficiency and infectivity of rescued virus from PK15 cells 
transfected with pSP72-1.1PCV2 and pSP72-PCV2 or infected with Bac-
1.1PCV2 and Bac-PCV2 were examined by IFA. Transfection efficiency was de-
termined 12 h after transfection or infection and viral infectivity was determined 
by inoculating PK15 cells with another passage of rescued virus. Briefly, PK15 
cells were washed with PBS and fixed with 4% paraformaldehyde for 15 min at 
room temperature, followed by permeabilisation with PBS containing 0.1% Tri-
ton X-100 for 30 s and blocking with 1% BSA in PBS for 2 h. Primary antibod-
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ies against the Cap protein were used for incubation with the cells for 1 h. After 
washing, secondary antibodies Alexa Fluor-488 donkey anti-mouse IgG or IgM 
(Invitrogen, USA) were used to facilitate visualisation. Stained monolayer cells 
were viewed on an Olympus IX70 inverted fluorescence microscope (Olympus, 
Japan). To evaluate the effects of baculovirus vectors on cell viability, wild-type 
baculovirus was used to infect PK15 cells as a control. 
Morphological observations of PCV2 
The supernatants of virus stocks after ten passages were collected and in-
cubated with monoclonal antibodies against the Cap protein overnight at 4 °C, 
and then centrifuged at 13,000 rpm for 30 min. Concentrated virus was allowed 
to adsorb onto carbon-coated copper grids for 5 min, then the girds were dried 
using filter paper and negatively stained with 3% phosphotungstic acid (PTA) for 
2 min. The samples were examined at a magnification of ×30,000 using a Hitachi 
H500 transmission electron microscope. 
Viral titration of rescued PCV2 
Virus titres in cell cultures were determined by a microtitration infectivity 
assay recorded as TCID50/ml by using the method of Reed and Muench (Reed 
and Muench, 1938). 
 
Results 
Preparation of recombinant baculovirus containing 1.1 copy of PCV2 genome 
The 1.1 copies of PCV2 genomic DNA were constructed from two frag-
ments (SL-rep, 1077 bp and cap SL, 862 bp; Fig. 1A), and the resultant recombi-
nant baculovirus contained two copies of stem loops (Fig. 1B). After amplifica-
tion, the titre (plaque assay) of the baculovirus reached 1 × 108 pfu/ml. 
Generation of PCV2 in PK15 cells infected with recombinant baculovirus 
After PK15 cells were infected with recombinant baculovirus (Bac-PCV2 
and Bac-1.1PCV2), the supernatant harvested from the cell culture was re-
inoculated into fresh PK15 cells. Furthermore, virus stocks were propagated for 
10 passages and TCID50 was measured in each passage (Fig. 2B). We concluded 
that PCV2 was successfully rescued from PK15 cells infected with recombinant 
baculovirus containing either 1 copy of PCV2 genome or 1.1 copies of PCV2 
genomes with two stem loops. As control, PCV2 was also rescued from a cell 
culture with plasmid transfection. It was noteworthy that the PCV2 rescued from 
the recombinant baculovirus (Bac-1.1PCV2) had a higher titre than others from 
the first passage. Regarding the morphology of PCV2 rescued from PK15 cells 
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infected with recombinant baculovirus (Bac-1.1PCV2), virus stock at passage 10 
had spherical particles ~17 nm in diameter (Fig. 2A). 
 
Fig. 1. Schematic diagram of plasmid construction. (A) 1 copy PCV2 genome construct. Linear full 
length of the PCV2 genome with one potential stem-loop structure was amplified by PCR and  
inserted into a pSP72 and a pFastBacI vector, respectively. (B) 1.1 copy PCV2 genome construct. 
1.1 copy of PCV2 genome with two potential stem-loop structures were amplified by overlap PCR 
and inserted into a pSP72 and a pFastBacI vector, respectively 
 
 
Fig. 2. Electron micrograph and viral titre of rescued virus. (A) Negatively stained PCV2 particles 
at passage 10 in PK15 cells infected with 100 multiplicities of infection (MOI) recombinant  
baculovirus; the diameter of rescued virus particles was about 17 nm. (B) Viral titre of PCV2 in the 
supernatant at different passages. The titres strikingly increased at the third passage and reached 
106.5 TCID50/ml 
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Characterisation of viral gene expression in PK15 cells transfected with  
recombinant baculovirus 
To further verify that PCV2 was rescued and propagated in PK15 cells, 
the expression of two major viral genes was detected by RT-PCR and subsequent 
DNA sequencing. As expected, specific bands of cap (702 bp) and rep (945 bp) 
genes were detected when total RNA was used as template. Viral cap transcripts 
were 10 times more than rep transcripts when using the same quantities of tem-
plate RNAs (Fig. 3A, lanes 3 and 5). As control, RT-PCR was also used to detect 
viral gene transcripts in PK15 cells transfected with pSP72-1.1PCV2 and pSP72-
PCV2 (Fig. 3A, lanes 4 and 6). Wild-type baculovirus and PCV2-infected cells 
were used as negative control and positive control, respectively (Fig. 3A, lanes 1 
and 2). 
Next, expression of the capsid protein (Cap) in PK15 cells was determined 
72 h after the cells had been infected with recombinant baculovirus (Bac-1.1PCV2 
or Bac-PCV2). Based on Western blot, PCV2 Cap was detected in PK15 cells in-
fected with recombinant baculovirus (Fig. 3B, lanes 3 and 5) or recombinant 
pSP72 vector (Fig. 3B, lanes 4 and 6). Wild-type baculovirus and PCV2-infected 
cells were used as negative control and positive control, respectively (Fig. 3B, 
lanes 1 and 2). Transfection efficiency was confirmed by IFA 12 h after infec-
tion; infected PK15 cells had nuclear staining or plasma staining with anti-PCV2 
monoclonal antibodies (Fig. 4B, C, E, F). Infection with Bac-1.1PCV2 and Bac-
PCV2 resulted in 40–60% positive cells, whereas pSP72-1.1PCV2 and pSP72-
PCV2 had 20–40% positive cells, with no staining apparent in mock-infected or 
wild-type baculovirus infected PK15 cells (Fig. 4A, D). 
 
 
Fig. 3. Reverse transcription PCR and Western blot. (A) Two major viral gene transcripts were  
detected by reverse transcript PCR with the specific primers when the total RNA of PK15 cells  
infected with 100 MOI Bac-1.1PCV2 or Bac-PCV2 was used as template. (B) PK15 cells infected 
100 MOI Bac-1.1PCV2 or Bac-PCV2 were harvested and total cellular protein was used in  
Western blot analysis with a specific antibody to structural protein Cap. Specific anti-Cap antibody 
recognised the 27.8 kDa structure protein Cap of PCV2 
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Discussion 
PCV2-infected PK15 cell cultures contain only low titres (~105–106 
TCID50/ml) of virus (Guo et al., 2011), and consequently the development of in-
activated PCV2 vaccines has been limited. In addition, PCV2 with a high titre 
would be useful to study PCV2 replication and for in vitro diagnosis of PCV2 in-
fection. The preparation of a PCV2 infectious clone, a reliable method to rescue 
virus in the laboratory, could modify the viral genome at a molecular level, with 
the potential to increase PCV2 titres. To date, two laboratory-based platforms 
have been used to rescue PCV2. One approach is based on chemical transient 
transfection (Huang et al., 2012; Li et al., 2015), and the other approach used 
suspension cultures of invertebrate cells, such as the production of rAAV (re-
combinant Adeno-associated virus) vectors in insect cells (Kotin, 2011). In the 
present study, two PCV2 strains (Bac-PCV2 and Bac-1.1PCV2) with higher ti-
tres were rescued from recombinant baculovirus. The stability of the rescued 
PCV2 in PK15 cells over 10 serial passages was verified by IFA and DNA se-
quencing conformation. This is apparently the first report on obtaining PCV2 
strains via baculovirus infection, although infectious clones for other viruses 
have already been rescued by baculovirus (Lucifora et al., 2008). 
If two identical or similar sequences are present within one DNA mole-
cule, this molecule may undergo homologous recombination (Valerie and Povirk, 
2003; West, 2003). Furthermore, infectious virus can be generated from bacterial 
constructs or mammalian cells containing head-to-tail tandem repeat PCV ge-
nomes with two origins (Oris) for DNA replication (Cheung, 2006; Fenaux et al., 
2002; Fenaux et al., 2003; Roca et al., 2004) or self-ligation of genomic DNA 
(Guo et al., 2011) upon transfection into mammalian tissue culture cells. In this 
study, we evaluated the role of stem-loop structure in the virus rescue. PCV2 vi-
rus strains were rescued from 1.1 copy PCV2 genome containing two stem-loop 
structures (pSP72-1.1PCV2 infectious clone), which yields a higher expression 
of viral protein and a higher titre of virus than the 1 copy PCV2 genome contain-
ing one stem-loop structure (pSP72-1PCV2 infectious clone). The rep gene 
mRNA transcripts essential for viral DNA replication (Cheung, 2006) of two in-
fectious clones were detected in transfected cells by RT-PCR (Fig. 3A). The fact 
that the splice-joint rep’ gene transcript was not detected in this study (data not 
shown) implies a smaller quantity of mRNA transcript, consistent with the find-
ings of a previous study regarding transcription of PCV2 in PK15 cells (Cheung, 
2003a). When this plasmid was applied in vitro, 40% of cells transfected with 
pSP72-1.1PCV2 had a higher expression of viral capsid antigen protein than 
20% of the cells transfected with pSP72-PCV2 (based on IFA). 
Rolling-circle replication (RCR), one of the most effective and simplest 
replication strategies, is used by several plasmids and virus (Ruiz-Masó et al., 
2015). Based on the analysis of common features from the initiator Rep protein 
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and stem-loop structure of PCV2, it has been proposed that PCVs, e.g. Gemi-
niviridae and Nanoviridae, replicate using a RCR strategy (Gutierrez, 1999; 
Stenger et al., 1991). In the RCR mechanism, initiation and termination of DNA 
replication depend on a stem-loop structure (Allan et al., 2012; Cheung, 2012). A 
bacterial plasmid containing 1.75 copies of double-stranded porcine circovirus 
DNA (0.8 copy of PCV1, 0.95 copy of PCV2) in tandem with two origins of 
DNA replication (Ori) yielded a unit-length chimerical PCV1/PCV2 genome, 
which was transformed into Escherichia coli for virus rescue (Cheung, 2006). 
This was consistent with reports that accumulation of viral replicative-form 
DNAs of geminiviruses in bacteria depended on the presence of two Oris in the 
plasmid constructs (Selth et al., 2002). In this study, virus rescued from pSP72-
1.1PCV2 resulted in higher PCV2 replication than pSP72-PCV2. Therefore, we 
inferred that the 1.1 copy PCV2 was more efficient to generate ssDNA molecule 
than the 1 copy PCV2. The PCV2 produced by pSP72-1.1PCV2 was likely gen-
erated via the RCR copy-release mechanism, in a manner similar to that de-
scribed previously (Cheung, 2012). We inferred that PCV2 DNA synthesis was 
initiated at one Ori and terminated at another Ori of the same molecule. During 
initiation, the PCV Rep protein cleaves the PCV Oc8 sequence in one stem loop 
to generate a 3’-OH end for leading-stranding DNA synthesis, and polymerisa-
tion is done by mammalian replication machinery. During termination, Rep nicks 
another Oc8 sequence in another stem loop and then reconstitutes the Ori by 
joining the ends of the displaced PCV2 genome and releasing the circular 
ssPCV2 molecule (Cheung, 2004). Compared to RCR replication mediated two 
stem-loop structures (pSP72-1.1PCV2), less PCV2 DNA replication occurred in 
pSP72-PCV2 in spite of the same vector, perhaps because one stem-loop in 
pSP72-PCV2 might be less well adapted to generate a unit-length PCV2 genome. 
The infectious clone generated by pSP72-PCV2 was likely due to the virus re-
circularised by the homologous recombinant, which then jumped out of the 
plasmid backbone to initiate a natural infection. 
The formation of recombinant baculovirus without viral replication or cy-
topathic effects has been used as an excellent vector to deliver and express ex-
ogenous genes in mammalian cells (Airenne et al., 2009; Sung et al., 2014) by 
simply adding viral inocula to these cells (Ho et al., 2005). In addition, the bacu-
lovirus technology offers an alternative to scalable virus production, due to the 
rapid and easy production of baculovirus, the efficient transduction of cells and 
the safety of baculovirus. Furthermore, baculovirus can deliver Hepatitis C virus 
(HCV) genome DNA into HepG2 cells to produce infectious HCV (Yao et al., 
2008). Subsequently, functional lentivirus vectors were generated in adhered or 
suspended 293T cells using recombinant baculovirus (Lesch et al., 2008; Lesch 
et al., 2011). In this study, Bac-PCV2 and Bac-1.1PCV2 produced higher titres 
than pSP72-PCV2 and pSP72-1.1PCV2 in PK15 cells when infected at 100 
MOI. In our study, baculovirus provided high transduction efficiency (60% of 
288 CAI et al. 
Acta Veterinaria Hungarica 65, 2017 
the cells expressed the PCV2 viral antigen), compared to the chemical transient 
transfection approach (with only 40% of the PK15 cells expressing the PCV2 vi-
ral antigen). The amount of plasmids and chemical reagent determines the 
maximum number of transfected cells and the amount of virus produced (Guo et 
al., 2011), whereas the polycationic compound formed by the plasmids is toxic to 
the cells, which might have contributed to the low percentage of PK15 cells. 
In summary, we developed an efficient and reliable baculovirus-mediated 
system for introducing the PCV2 genome into PK15 cells and acquiring infec-
tious virus, which provided a superior alternative to existing production methods. 
In addition, we have demonstrated that the stem-loop structure was very impor-
tant in virus rescue. To our knowledge, this is the first demonstration of PCV2 
rescue based on recombinant baculovirus infection. Applications of this cell cul-
ture system are expected to be useful in the basic study of PCV2. 
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